Jul 1, 2026 09:30AM
Jul 1, 2026 09:30AM
Jun 22, 2026 04:41PM
Jun 22, 2026 07:00AM
Jun 22, 2026 07:00AM
Jun 8, 2026 07:02AM
Jun 8, 2026 07:00AM Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine
May 13, 2026 04:05PM
Apr 30, 2026 08:15AM
Mar 19, 2026 05:10PM
Mar 16, 2026 07:02AM
Mar 16, 2026 07:00AM
Mar 10, 2026 07:02AM
Mar 10, 2026 07:00AM Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
Jan 8, 2026 04:07PM
Jan 8, 2026 04:05PM
Nov 18, 2025 06:31AM
Nov 14, 2025 05:00PM
Nov 6, 2025 06:30PM
Nov 6, 2025 06:30PM
Aug 6, 2025 04:01PM Eledon presents updated kidney transplant drug trial data
Aug 6, 2025 04:01PM
Feb 7, 2025 10:00AM
Feb 7, 2025 10:00AM
Oct 23, 2023 07:01AM
Oct 23, 2023 07:00AM
Sep 11, 2023 07:02AM
Sep 11, 2023 07:00AM Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
Jan 9, 2023 08:31AM
Jan 9, 2023 08:31AM
Jan 9, 2023 08:30AM
Jan 9, 2023 08:30AM
Nov 14, 2022 04:01PM
Nov 14, 2022 04:01PM
Sep 7, 2022 09:19AM Pre-Open Movers: UiPath Sinks Following Results, Coupa Software Gains
Sep 6, 2022 05:34PM
Sep 6, 2022 04:03PM
Sep 6, 2022 04:01PM
Sep 6, 2022 04:01PM
Aug 11, 2022 04:01PM
Aug 11, 2022 04:01PM
Aug 1, 2022 05:49AM Eledon Pharmaceuticals (ELDN) Granted FDA Clearance of IND Application to Evaluate Tegoprubart
Aug 1, 2022 05:00AM
Aug 1, 2022 05:00AM
Jun 9, 2022 08:03AM
Jun 9, 2022 08:00AM
Jun 9, 2022 08:00AM
May 31, 2022 06:09AM
May 31, 2022 06:00AM Eledon Announces Positive Topline Results from Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis
May 31, 2022 06:00AM

326,367 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All